BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32284180)

  • 1. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.
    Kimura T; Ito M; Onozawa S
    J Infect Chemother; 2020 Jul; 26(7):706-714. PubMed ID: 32284180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.
    Reissig A; Mempel C; Schumacher U; Copetti R; Gross F; Aliberti S
    Lung; 2013 Jun; 191(3):239-46. PubMed ID: 23564195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study.
    Yoon YK; Kim EJ; Chun BC; Eom JS; Park DW; Sohn JW; Kim MJ
    Respirology; 2012 Jan; 17(1):172-9. PubMed ID: 21995414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.
    Marcos PJ; Restrepo MI; Sanjuàn P; Ferreira-Gonzalez L; Verea-Hernando H
    Hosp Pract (1995); 2013 Aug; 41(3):7-14. PubMed ID: 23948616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia.
    Hagaman JT; Yurkowski P; Trott A; Rouan GW
    Am J Med Qual; 2005; 20(1):15-21. PubMed ID: 15782751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
    Kohno S; Yanagihara K; Yamamoto Y; Tokimatsu I; Hiramatsu K; Higa F; Tateyama M; Fujita J; Kadota J
    J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
    Piso RJ; Arnold C; Bassetti S
    Swiss Med Wkly; 2013; 143():w13870. PubMed ID: 24089030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia.
    Deshpande A; Klompas M; Guo N; Imrey PB; Pallotta AM; Higgins T; Haessler S; Zilberberg MD; Lindenauer PK; Rothberg MB
    Clin Infect Dis; 2023 Jul; 77(2):174-185. PubMed ID: 37011018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India.
    Kotwani A; Kumar S; Swain PK; Suri JC; Gaur SN
    Indian J Pharmacol; 2015; 47(4):375-82. PubMed ID: 26288468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
    Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
    File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD
    Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapeutic aspect of antibiotic therapy during acute community-acquired pneumonia in adults at the University Hospital of Cocody (Abidjan).
    Kouakou-Siransy G; Horo K; Effo E; Kamenan A; N'guessan-Irié G; Boko-Kouassi A; Aka-Anguy E; Die Kakou H
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):940-6. PubMed ID: 26413732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
    Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.
    Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB
    Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: the MAREA study.
    Di Pietro P; Della Casa Alberighi O; Silvestri M; Tosca MA; Ruocco A; Conforti G; Rossi GA; Castagnola E; Merlano MC; Zappettini S; Renna S;
    Ital J Pediatr; 2017 Dec; 43(1):113. PubMed ID: 29273072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia.
    van der Eerden MM; de Graaff CS; Vlaspolder F; Bronsveld W; Jansen HM; Boersma WG
    Clin Ther; 2004 Feb; 26(2):294-303. PubMed ID: 15038952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous beta-lactam plus a macrolide to an oral respiratory fluoroquinolone.
    Shindo Y; Sato S; Maruyama E; Ohashi T; Ogawa M; Imaizumi K; Hasegawa Y
    Intern Med; 2008; 47(21):1865-74. PubMed ID: 18981629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
    Matsushima T;
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():677-81. PubMed ID: 12722300
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies for early discharge of the hospitalized patient with community-acquired pneumonia.
    Siegel RE
    Clin Chest Med; 1999 Sep; 20(3):599-605. PubMed ID: 10516907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.